Author

Marissa Middlecamp

Institution: Mapp Biopharmaceutical (United States)

Observed institution: Mapp Biopharmaceutical (United States)

ORCID: 0009-0002-7363-8980

Observed ORCID: 0009-0002-7363-8980

OpenAlex ID: A5094079113

Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread

2025 · Felix Pahmeier, Stephanie R. Monticelli, et al. · Science Translational Medicine · 32

Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38

2024 · Olivia S. Shin, Stephanie R. Monticelli, et al. · Cell Reports · 21

Avidity and variable domain spacing strongly influence the therapeutic potency of bispecific antibodies against Crimean-Congo hemorrhagic fever virus

2025 · Albert Wang, Stephanie R. Monticelli, et al. · mBio · 4

Works count: 3

Citation count: 57

H-index: 3

I10-index: 2